1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

PURPOSE: The aim of this study was to assess the effectiveness and safety of ILUVIEN® in patients with chronic diabetic macular edema (DME) who were insufficiently responsive to prior therapies. METHODS: This is a prospective, nonrandomized, multicenter, open-label, phase 4 pilot study assessing the effectiveness and safety of ILUVIEN® involving 12 patients insufficiently responsive to available therapies. Assessments were performed at screening, baseline, week 1, and months 1, 3, 6, 9, and 12. Demographics, medical/ophthalmic history, prior laser, anti-VEGF, and steroid treatments, and lab tests were recorded at screening. A complete ophthalmic examination and SD-OCT were performed at screening and at all follow-up visits. RESULTS: The patients showed improvements in best-corrected visual acuity (+3.7 letters), with greater improvement among pseudophakic patients (+6.8 letters) compared with phakic patients (-2.5 letters) 12 months after ILUVIEN®. The mean central subfield thickness decrease from baseline to month 12 was statistically significant, with a rapid reduction in the first week. Regarding safety, only 2 patients showed an intraocular pressure (IOP) increase over 25 mm Hg during the study, and the rise in IOP was well managed with eye drops only. CONCLUSIONS: This prospective and pilot study suggests that ILUVIEN® is safe and may be considered effective for chronic DME patients insufficiently responsive to other available therapies as it showed a rapid and sustained improvement of macular edema obtained after treatment with ILUVIEN®.

Pertenece a

Repositório Comum  

Autor(es)

Figueira, J -  Henriques, J -  Amaro, M -  Rosas, V -  Alves, D -  Cunha -  Vaz, J - 

Id.: 69635351

Idioma: eng  - 

Versión: 1.0

Estado: Final

Palabras claveRetinopatia Diabética - 

Tipo de recurso: article  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

: openAccess

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 13-feb-2017

Contacto:

Localización:
* Ophthalmic Res. 2017 Feb 9. doi: 10.1159/000455235. [Epub ahead of print]
* 10.1159/000455235

Otros recursos del mismo autor(es)

  1. The Detailed Science Case for the Maunakea Spectroscopic Explorer: the Composition and Dynamics of the Faint Universe International audience
  2. Prevenção de AVC : contributo dos farmacêuticos para a saúde pública Dissertação para obtenção do grau de Mestre no Instituto Superior de Ciências da Saúde Egas Moniz
  3. Anisaquíase : revisão de uma parasitose emergente causada por Anisakis spp Dissertação para obtenção do grau de Mestre no Instituto Superior de Ciências da Saúde Egas Moniz
  4. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial Background: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The strok...
  5. Zika virus can be venereally transmitted between Aedes aegypti mosquitoes. International audience

Otros recursos de la mismacolección

  1. Impacto Alimentar Esofágico, um Dilema Diagnóstico O impacto alimentar esofágico é uma situação que na maioria dos casos é secundária a patologia esofá...
  2. Mononucleose Infeciosa e Hepatite Colestática: Uma Associação Rara A mononucleose infeciosa é uma das principais manifestações clínicas da infeção pelo vírus Epstein-B...
  3. Caso Clínico Interactivo: Lesões Cutâneas em Recém-Nascido info:eu-repo/semantics/publishedVersion
  4. A large outbreak of Legionnaires’ Disease in an industrial town in Portugal Background We describe the investigation and control of an outbreak of Legionnaires’ disease in Por...
  5. Sépsis neonatal tardia a Streptococcus do grupo a – um agente improvável info:eu-repo/semantics/publishedVersion

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.